According to today's Daily Mail, veterinary surgeon Lis Crowsley may have been killed as she tried to protect her dogs from cows that were with their newly-born calves.
Click here for the full story.
Petplan has launched a new system through which veterinary staff at Appointed Representative (AR) practices can activate 4 weeks Immediate Veterinary Cover (IVC) for clients' puppies, kittens and rabbits at www.petplanvet.co.uk.
Petplan says the new system will greatly improve its service to the veterinary industry, enabling same day information transfer, reducing the amount of paperwork and admin for veterinary staff as well as ruling out the chances of paperwork getting lost or delayed in the post.
Simon Masding, Petplan Head of Sales and Partnerships said: "Petplan has the most established cover note scheme in the market and due to the strength of our brand and the products we offer is able to generate more insured clients for practices than any other provider. Our team of Account Executives visit practices across the UK on a daily basis which means we understand the pressures of day-to-day practice life. Our new online IVC service is just one of the innovative ways we try to make things easier for veterinary staff so they can focus on looking after clients and their pets."
For more information about becoming a Petplan AR practice, and Immediate Veterinary Cover, call Petplan's Vetline on 0800 316 8800.
Any practices that activate IVC online at petplanvet.co.uk before 31st July 2012 will be entered into a prize draw to win an iPad.
The Animal Health Trust is appealing to veterinary surgeons and nurses to encourage clients who keep their horses on premises that have been affected by Equine Grass Sickness to sign up to the second year of its nationwide EGS vaccine trial.
Equine Grass Sickness (EGS) occurs predominantly in Europe, with Britain experiencing the highest incidence worldwide. In 2014, 59 cases of EGS were reported through the EGS Surveillance Scheme, but it is likely that this represents only a fraction of cases occurring annually throughout Britain.
Almost all cases of EGS occur in horses with access to grazing. The AHT says there is growing scientific evidence to suggest that the disease may be caused by the bacterium Clostridium botulinum type C, commonly found within soil and capable of producing neurotoxins to which horses are particularly sensitive. EGS occurs when a combination of risk factors trigger the production of these toxins within the horse's intestinal tract, causing damage to the nervous system and paralysis of the gut.
As similar equine diseases such as tetanus and botulism can be prevented by vaccination, it is theoretically possible that a vaccine could prevent EGS. To this end the AHT, in collaboration with the Universities of Edinburgh, Liverpool and Surrey launched the EGS field vaccine trial in 2014 in order to establish whether a vaccine could indeed be effective in reducing the risk of the disease. The trial is funded by a number of sources including Neogen Corporation; Animal Welfare Foundation; Horserace Betting Levy Board; Racing Foundation; Moredun Foundation Equine Grass Sickness Fund; Hong Kong Jockey Club; The British Horse Society and the EB Moller Charitable Trust.
Now entering its second year, the EGS vaccine trial involves enrolled horses and ponies receiving either a course of the C. botulinum type C toxoid vaccine or an inactive placebo, as well as an annual booster. The incidence of EGS is monitored throughout the trial to determine the efficacy of the vaccine, and enrolled horses and ponies are closely monitored through regular follow-ups for the duration of the trial.
With 60% of EGS cases occurring during April - June, the highest risk season for EGS is fast approaching. The AHT is appealing to owners who keep their horses on premises that have had at least one case of EGS in the past three years to enrol their horse in the vaccine trial and provide an invaluable contribution to this pioneering research prior to these high risk months. Veterinary practices with clients who fit this description are asked to help the recruitment process by encouraging suitable cases to sign up to the trial.
Dr Jo Ireland, the AHT's Equine Grass Sickness Research Co-ordinator, said: "We have been delighted with the overwhelmingly positive response to the EGS vaccine trial and many owners have welcomed the chance to be a part of such important research. We don't want any eligible horse owners to miss out on the opportunity to contribute towards a potential breakthrough in the prevention of EGS, so we are encouraging more owners to enrol their horses on the trial this year."
To find out more about the vaccine trial or how clients can enrol horses and ponies, visit the AHT's dedicated EGS website www.equinegrasssickness.co.uk or email equinegrasssickness@aht.org.uk.
Idexx Laboratories has launched a new renal function test, Idexx SDMA, which the company says can detect chronic kidney disease (CKD) in dogs or cats months or even years earlier than traditional methods.
The test is based on a new renal biomarker - symmetric dimethylarginine (SDMA) - and is the result of collaboration with a number of global experts.
Simon Wootton, UK CAG Marketing Manager at Idexx said: "The high sensitivity of this marker for detecting CKD will allow vets to diagnose the disease a lot sooner than has been previously possible. Identifying the disease earlier will give vets more time to intervene and prescribe an appropriate course of action."
The company says that the Idexx SDMA test can identify renal disease in dogs up to nine months earlier than previous methods, while in cats the detection time can be up to 17 months earlier.
Dr Martha Cannon, BA VetMB DSAM(fel) RCVS Recognised Specialist in Feline Medicine of the Oxford Cat Clinic, said: "The launch of SDMA testing is very exciting. It offers the prospect of identifying chronic kidney disease at an earlier stage, which should mean we can treat it more effectively and allow us to maintain cats in the asymptomatic phase. This can improve longevity, but more importantly could help maintain a better quality of life for longer.
"SDMA is also unaffected by muscle loss, which will allow us to assess the true extent of CKD in our elderly and underweight cats. This will lead to improved treatment choices, better quality of life and more peace of mind for owners."
The value of the new test has been validated by the adoption of SDMA into the International Renal Interest Society (IRIS) guidelines as a biomarker for the early detection of CKD.
Jonathan W. Ayers, President and Chief Executive Officer of Idexx Laboratories, said: "Idexx SDMA is a result of our commitment to lead the industry in sustained research investments that serve to advance veterinary medicine. It represents a significant achievement in veterinary diagnostics. Hospitals in the USA already using Idexx SDMA have told us that it has transformed the way renal disease is diagnosed and treated."
Idexx SDMA is available to UK and Ireland reference laboratory customers now. Further information is available at www.idexxsdma.com.
Video shows Sylvia Conway MRCVS, UK Medical Affairs Consultant at Idexx, talking about the new test (can also be viewed here).
The College says this will pave the way for new diagnostic tests for what could be one of the most common causes of pregnancy loss in mares.
The researchers, led by Dr Mandi de Mestre (pictured right), Reader in Reproductive Immunology and Head of the Equine Pregnancy Laboratory at the RVC, collaborated with seven different veterinary practices to gain access to samples from across the UK and Ireland and found that around 20% of the pregnancies lost were aneuploid, which is when a copy of a whole chromosome is either duplicated or lost (similar to Down's).
Charlotte Shilton, RVC PhD, the student who performed the analysis, applied three different genetic approaches to confirm the results.
Work is now underway to identify the underlying cause of these aneuploid pregnancies, with early data from this study suggesting it is most commonly introduced via the egg or sperm. Until now, chromosomal defects such as aneuploidy have only been reported as a rare condition in young horses with developmental disorders.
The researchers say the study explains why the condition is so rare in horses, with most embryos and foetuses possessing this genetic change dying very early in development, as is also observed in human pregnancy. The study highlights the need to reconsider this genetic condition both in pregnancy loss but also for early developmental disorders.
Dr Mandi de Mestre, Reader in Reproductive Immunology at the RVC, said: “Early pregnancy loss remains a very frustrating condition for clinicians to treat as the underlying cause is unknown in around 80% of cases. These findings will allow researchers to develop new diagnostic tests for pregnancy losses, which would offer hope to thousands of owners of breeding mares that suffer this condition.
“A diagnostic test would allow them to make informed decisions on treatment strategies and to advise on whether they should invest in further attempts to breed their mare benefiting both horses and their breeders alike in the future. I would like to thank both the Thoroughbred Breeders Association and our collaborators at Texas A&M University and the participating veterinary surgeons for their support on this project.
Reference
The campaign comprises of a series of live interviews, articles and surveys aimed at exploring the impact of breast cancer, menopause, infertility and baby loss women, and men, and how the veterinary profession can better support people having to cope with these issues in the workplace.
The campaign includes free access articles and live online sessions with VetYourBreasts campaign organiser, veterinary surgeon Anna Beber, as part of Breast Cancer Awareness Month; VetMINDS co-founder, vet Nat Scroggie, on 12th October during Baby Loss Awareness Week; Dr Karen Morton, consultant obstetrician and gynaecologist on World Menopause Day 18th October; and SPVS Senior Vice President, Catriona Curtis, talking about her personal experiences with infertility on 2nd November during National Fertility Week.
A survey on the impact of the menopause, particularly on working life, is being run in partnership with SPVS in the run up to World Menopause Day. The survey seeks to gain a broad understanding of both awareness and experience across the profession, and responses are encouraged from all ages and genders, whether personally affected or not. The survey can be accessed here until 15th October: https://bit.ly/2FVXIkv
SPVS President, Anna Judson, said: "Having experienced the effects of the menopause working as a practice owner, I wish I had known more about the impact and that I was not alone in how I was feeling. There is a growing appetite to tackle these issues and we want to hear from anyone affected by the menopause, in order to put the right support mechanisms in place. We're proud to sponsor the menopause webinar and partner with Veterinary Woman on raising awareness about health issues, which are often brushed under the carpet."
Liz Barton, editor of Veterinary Woman, said: "I have been incredibly moved to see the deep empathy and encouragement amongst veterinary colleagues beginning to open up about the impact of health challenges, particularly at work. When I realised the campaigns in October were topics we need to talk about more as a profession, it seemed right to use this as a platform to tackle some of the hidden, emotive health challenges we bear throughout our life and work. We are looking for partners to help us develop the conversations and practical assistance for individuals and practices, to better support those who are silently living with these burdens."
Companies and organisations wishing to support the work should contact liz@veterinarywoman.co.uk. Individuals can register for updates about how to access the sessions by joining the Veterinary Woman email list for updates (www.veterinarywoman.co.uk), or following Veterinary Woman on social media.
For the research, Which? conducted an online poll of 1,009 pet owners who had had an issue with their vet in the past two years.
It also conducted qualitative interviews with 14 owners who had complained.
The most common reasons for complaint were:
Of the 1009 pet owners who had experienced some kind of problem with their vet, 57% did NOT make a complaint, 33% because they did not want to fall out with their vet.
Pet owners who wish to complain about veterinary services have three options: to complain directly to their practice, to use the voluntary Vet Client Mediation Service (VCMS), or to raise a 'concern' with the RCVS.
The Which? report found that of those who did complain to their practice, 35% were not happy with the outcome and 31% with the way it was handled.
Which? found that although the VCMS reported a high resolution rate of 84% in 2022-23, its interviewees had found it a bit hit or miss.
Finally, Which? found the process of complaining to the regulator flawed by the fact that the threshold for the College to progress a 'concern' is set so high, because College has no jurisdiction at a practice level, and because it has no sanctions to use in enforcing consumer law.
The report recommends that:
Full report: https://www.which.co.uk/policy-and-insight/article/complaints-and-redress-in-veterinary-services-a5z611X9tZzf
CommentI loved the regal response from the RCVS to The Guardian about the case studies in the Which? report: “the facts presented in the case studies do not completely align with those reported to us”.
That aside, surely the big issue here is not so much that consumers have little way to complain effectively.
That is important, of course, but isn't it more important to consider what they are complaining about, which in the main is MONEY.
Driven by the advances in veterinary medicine, the innate desire of vets to provide the best possible care, anthropomorphising pet owners saying they want 'the best' for their fur baby (without necessarily having the wherewithal), corporatisation and society's changing expectations about working conditions, prices have been going up at a rate far outstripping inflation.
Increasing prices have of course been accompanied by an increase the standards of care and the range of clinical equipment.
But the question everyone must ask is at what point the cost of veterinary care for a dog outstrips the benefits of owning one?
These complaints are the canary in the coalmine.
The UK's first online gastric ulcer risk assessment for horse owners has just been launched as part of the 2009 Gastric Ulcer Awareness Month (GUAM), organised by Merial Equine Health.
Merial has developed the risk online questionnaire to enable owners to evaluate their horse's risk of ulcers. By logging on to the website http://www.gastriculcerrisk.co.uk/, owners, trainers and riders can complete a form which then returns the results via email. Where an animal is considered to be at medium to high risk, owners will be advised to consult their veterinary practice.
The company's Dr Emma Batson said: "Since the first GUAM in 2007, significant progress has been made in developing awareness and understanding of equine gastric ulcer syndrome.
"However there is still more to do! Our goal is to move gastric ulcers further up the diagnostic process, such that the condition is an early consideration for all horses presented with the vague symptoms associated with ulceration. We know that due to the vague nature of the symptoms, many of horses are suspected of other ailments such as back and teeth problems, general poor performance, or behavioural issues prior to being diagnosed with ulcers.
"This new initiative has been developed through consultation with practising internal medicine specialists. We hope it will help to highlight more cases and encourage clients into the practice with horses that are at genuine risk of ulcers. Further diagnosis, treatment and management measures can then be considered in consultation with the client.
"The website also has a veterinary page so that follow up information and any gastroscopy results can be recorded by the vet. We hope that this feedback will help generate some valuable data for the industry."
To help you promote this initiative, Merial has produced an impactful poster for use in practice waiting rooms, along with educational literature. The poster will be available as a loose insert in various publications during April and May.
For those practices which require a referral scoping service, Merial can put you in touch with three specialist consultants; Rachael Conwell (North) Dr.Tim Brazil (Midlands/nationwide) and Richard Hepburn (South West) who each provide a mobile scoping clinic.
Merial is also promising support for the mobile scoping service for the five practices that direct the largest number of clients to http://www.gastriculcerrisk.co.uk/
A number of events are also taking place during the month for vets, trainers and horse owners, including the following CPD events:
GUAM is supported by BEVA and Dr Batson hopes that the 2009 initiatives will further boost awareness, understanding and diagnosis of this underrated condition.
Animalcare has launched a new broad spectrum fluoroquinolone antimicrobial (Enrofloxacin) which the company says is highly effective in the treatment of a wide range of conditions and easy to inject, with excellent tissue penetration.
Enrocare solution for injection is presented in three strengths: A 25mg/ml (2.5%) injection for dogs, cats and exotic animals including reptiles, small mammals and avian species. The 50mg/ml (5%) injection is licensed for use in cattle, pigs, dogs and cats, whilst the 100mg/ml (10%) injection is licensed for cattle and pigs. In the case of dogs and cats a single daily dose is needed.
Animalcare says it has priced Enrocare competitively. In addition, the range has been launched with three offers: "Buy one get one free on the 50 and 100mg/ml" and "Buy two get one free offer" on the 25mg/ml pack size. These offers will last for four months until the end of September.
In cattle, Enrocare 50mg/ml, given by the subcutaneous route, is licensed for respiratory disease of bacterial or mycoplasmal origin and the 100mg/ml strength is licenced for both respiratory disease and E.coli mastitis (the latter given by slow intravenous injection). According to Animalcare, its low dose volume makes it particularly suitable for the treatment of respiratory disease in calves. In pigs >25kg Enrocare is licensed for the treatment of the respiratory and alimentary tract diseases of bacterial or mycoplasmal origin and multi-factorial diseases such as atrophic rhinitis and enzootic pneumonia.
Tony Liepman, Animalcare Market Manager said: "The recent successful launch of Cephacare flavour raised Animalcare's profile as a supplier of more up-to-date antibiotics and this is our latest addition which offers excellent efficacy at an attractive price."
BCF has released a new bovine foetal sexing quick guide as a free download from the farm animal learning section of the company's website - www.bcftechnology.com.
To help vets learn the skill of foetal sex determination with ultrasound, the guide includes:
BCF says that using ultrasound for foetal sex determination can be useful to herd management programmes: you can estimate the number of replacement heifers, further justify the culling of a cow with chronic disease (mastitis, lameness etc.) and determine pricing for a sale and/or purchase.
The guides have been created by BCF in-house vet Kimberley Palgrave who said: "The bovine foetal sexing guide was created with the aim of giving vets a few tips to help them develop confidence in foetal sex determination using ultrasound. Hopefully this guide can help people feel more assured in their technique and enable them to obtain additional information that the farmer can use in their herd management programme."
Culture Change In Healthcare is presented by Simon Fleming, a trauma and orthopaedic registrar who has a special interest in combating bullying, undermining and harassment in human healthcare, and Sally Everitt MRCVS, the ex Head of Scientific Policy at BSAVA.
Simon will discuss the problem of bullying, the fallout from serious cases, and how you can work to eliminate bullying in your practice.
Sally will present the results of a survey carried out by VetSurgeon.org and VetNurse.co.uk in 2017, to investigate the incidence and impact of unpleasant behaviour in veterinary practice.
The webinar is hosted by The Webinar Vet and sponsored by RCVS Mind Matters. It counts as 1hr towards your annual CPD requirement.
Whether or not you think there is any bullying going on at your practice, I strongly urge you to watch this webinar. There can be few things as harmful to an effective practice team as bullying. Everyone needs to be able to spot it and stamp on it quickly.
Register for the webinar here: https://www.thewebinarvet.com/pages/culture-change-healthcare-2/
Feliway Help! comes as a starter pack with a pheromone cartridge which lasts seven days and covers 50m2.
The cartridge is inserted into a diffuser which is plugged into an electrical socket, two days before the stressful event.
Ceva says that 83% of cat owners saw an improvement in their cat’s signs of stress after using Feliway Help!1.
The company adds that the Feliway Help! is particularly useful for clients of those practices which Feliway on the premises, with Feliway helping keep the cat calm at the practice, and Feliway Help! taking over when they return home.
Sarah Heath BVSc PgCertVE DipECAWBM(BM) CCAB FRCVS, an RCVS and EBVS European Veterinary Specialist in Behavioural Medicine and Certified Clinical Animal Behaviourist, said: “Cats can find the veterinary visit challenging and when they go home they can sometimes find it hard to settle.
"Feliway Help! can be very beneficial in easing the transition between home and the practice.
"This can be particularly helpful when cats have had a stay in hospital.”
For more information, visit www.feliway.com/uk, call the Ceva Animal Health head office on 01494 781510 or email cevauk@ceva.com.
Conducted as a multicentric international study involving board-certified veterinary dermatologists, the trial included 35 dogs with CIF in at least two paws.
Each dog acted as its own control, and was treated with systemic antibiotics, with one paw being treated with FLE and the other paw without.
Paws were allocated based on a coin toss, and the study was single blinded: the principal investigator was responsible for the assessment of lesions, and the co-investigator was responsible for administration of FLE treatment.
The dogs were assessed over an 8-week period with check-ups every 14 days.
At every check-up the paws treated with FLE showed a greater improvement than paws without FLE treatment.
The lesions were assessed and scored with the global lesion score, the pruritic visual analogue scale, a cytological scoring, and photographic documentation.
The results of the study demonstrated that FLE combined with systemic antibiotics significantly reduced the time to clinical resolution compared to antibiotics alone.
By week four, 50% of paws in the FLE group had reached clinical resolution compared to 17% in the control group.
By week eight, 88% of paws in the FLE group had healed compared to 54% in the control group.
Dr Anja Lange, DVM, Department of Dermatology, AniCura Kleintierspezialisten Augsburg GmbH, Augsburg, Germany, said: “Canine interdigital furunculosis is a challenging condition to treat that can be prolonged and frustrating.
"Having FLE as an additional management tool is very exciting, not least because it speeds up time to healing, but it also requires us to use less antibiotics.
"The use of FLE was well accepted by all of the dog owners from the study and the dogs themselves tolerated it well, showing it can be a very useful adjunct to cases in clinical practice.”
Success in Veterinary Practice by Dr. Bradley Viner DProf BVetMed MSc(VetGP) MRCVS is now available from Wiley Blackwell at £28.99. Teeside general practitioner Rob Reid BVM&S MRCVS has reviewed the book for members of VetSurgeon.org:
There are many self-help books available in a variety of fields, covering topics which range from stress management and emotional control through to furthering one's career and professional development. Until now, there has been no such publication that has covered these issues in the veterinary context, and it is here that Bradley Viner has identified a niche in the market with his new book Success in Veterinary Practice.
The aim of book is to help veterinary practitioners of all levels to develop and nurture their professional skills, both on a personal and at a practice level. The book will be of interest to vets in all fields and contains a lot of information that will be particularly relevant to vets who are embarking on the Professional Key Skills Module of the RCVS CertAVP. It may also be of interest to other members of the veterinary practice team and is also marketed at individuals who are considering a career in the veterinary field.
The book is organised into nine chapters, with the first eight providing content matter on areas such as personal development, communication techniques, improving clinical performance and developing leadership skills, with the final chapter summarising the information presented. The first eight chapters are structured in such as way that information is presented in a digestible format. The material is detailed enough to provide understanding without being overburdening and the summary and exercise sections presented at the end of each chapter help the reader to review what they have read and pick out the key ideas.
There were many areas of the book I found interesting and I liked the way that the author has looked at the psychological and sociological aspects of one's actions, both in relation to colleagues in the workplace and in relation to dealing with clients. From a personal point of view, I also liked the section on communication skills - an area which probably doesn't receive enough coverage in both undergraduate and postgraduate education.
On the negative side, there are some minor typographical errors and I feel some of the diagrams could have been better produced. The pure academics among us may also be somewhat critical about the author's stance towards the relevance of some aspects of clinical research. And of course some people may be put off by the price, with the truly cynical among us possibly seeing the close relevance of the content to the syllabus of the CertAVP 'A' module as a cunning marketing ploy!
As a general practitioner, however, I found the book to be informative and thought-provoking. I have found it has encouraged me to take a look at certain aspects of my work which I have almost done instinctively in the past, analyse my reasons for doing them and then look at how I can improve on these in the future, for the good of patients, my clients, the rest of the working team and of course for myself. It is certainly an interesting read, and I would recommend it to be of value to any vet who sees the term 'professional development' to mean far more than a simple sharpening of one's clinical skills.
The survey of 97 cat owners and 156 vets conducted in June last year found that currently only 30% of cat owners give supplements to their cat but 74% would be willing to try them.
The survey also found that whilst 80% of vets thought the main reasons to be hesitant about recommending feline supplements were palatability and the owner’s ability to give products, owners were less concerned about the ease of giving the supplement (53%), and more concerned about the cost (45%) and being unsure of the benefits (39%).
Tara Evans RVN, head of sales at Vita, said: “It is interesting that the majority of vets believe that practicalities around administering oral supplements is the main drawback to giving these products, whereas only 53% of owners were concerned about this.
"Understanding owner concerns regarding efficacy and price could help vets support more owners to move forward with supplements for their cats.”
According to the survey, the most frequently used supplements, by both vets and owners are those made to support joints.
Cat owners also showed an interest in giving supplements for general wellness (61%).
Tara added: “Owners are open to supplementing for general health, as well as more specific health-related issues.”
www.vitaanimalhealth.com
The first phase of research is being conducted this January and February 2023 and will analyse the amount and distribution of UK canine health research funding over the past decade.
Veterinary associations, societies and charities which support canine health research tend to identify funding priorities aligned with their own strategy and scope, taking account of independent peer review from experts in the field of research.
However, the RVC says that as there are many research funders working independently, some important research topics may be overlooked and separately funded projects can inadvertently overlap in their work.
This study endeavours to investigate these issues and consider how resources are prioritised across different areas of canine research.
Participating stakeholders will be asked their opinions on future research funding and this information will contribute to developing a long-term strategy for not-for-profit UK canine health research.
Thereafter, the aim is to create a pilot consultation process for developing a central prioritisation platform for future collaborative canine research.
The RVC’s says it has already got data and support from several major funders but is keen to maximise the scope of this research, so it is now looking for participation from specialist veterinary societies that fund research, and non-university organisations, such as charities, corporates or independent referral practices which conduct their own in-house canine research.
Dr Alison Skipper, Postdoctoral Researcher into Canine Research Funding within VetCompass at the RVC said: “We are really keen to hear from as many non-profit organisations involved with canine health research funding as possible. The breadth and depth of this data is vital to ensure that our findings accurately reflect this sector."
For more information about how to get involved, please visit https://rvc.uk.com/canine-research-funding-analysis.
The practice is now accepting dental referrals, including for dental, oral and maxillofacial surgery.
Hannah said: “I am proud to join the Fitzpatrick Referrals team to extend their referral offering to include this very important aspect of small animal veterinary treatment.
"Working alongside a world-class team with state-of-the-art facilities is a fantastic opportunity.”
https://www.fitzpatrickreferrals.co.uk/services/dentistry/
Petplan has announced the finalists for the 2009 Veterinary Awards.
The company says it was inundated with more than 2300 nominations this year and that the public response was 'astonishing', with tales ranging from midnight rescues to simple acts of kindness and this year was no exception.
The finalists for each of the categories are as follows:
Vet of the YearJamie Rushton, Village Vet Hampstead, LondonBen Jones, Ben Jones Veterinary Surgery, Chester, FlintshireMatthew Fry, Quarrington Veterinary Surgery, Sleaford, Lincolnshire
Vet Nurse of the YearCharlotte Maude, Companion Care Veterinary Surgery Chesterfield, Markham, ChesterfieldKaren McQuaid, The Old Golfhouse Veterinary Group, Watton, NorfolkRachel Smith, 608 Veterinary Group, Solihull, West Midlands
Vet Receptionist of the YearYasmin Morowa, Melton Veterinary Surgery, Woodbridge, SuffolkJackie Crampton, Companion Care Veterinary Surgery Chesterfield, Markham, ChesterfieldSara Abbott, Pet Doctors, East Horsley, Surrey
Vet Practice of the YearAshfield House Veterinary Hospital Limited, Long Eaton, NottinghamshireCarrick Veterinary Group CVS (UK) Ltd, Newbold, ChesterfieldSt Clair Veterinary Group, Kirkcaldy, Fife
Simon Wheeler, Petplan's Head of Marketing said he was thrilled by the record number of nominations received:
"This year we are celebrating the tenth anniversary of the Veterinary Awards which were launched so pet owners could thank their practice for the tireless and wonderful work they carry out. We are delighted that the awards, which we often hear referred to as the 'Vet Oscars', are still going strong. This year we have received over 2300 nominations and the quality and standard really challenged the skills of our esteemed judging panel. We would like to wish those short listed every success on the night."
All finalists will be invited to a 'glittering' awards ceremony that will take place on 2nd April at the Burlington Hotel in Birmingham where the winners will be announced.
Together, these two cancers account for almost a third of all canine cancers.
Dr. Heather Wilson-Robles, an Associate Professor at Texas A&M University and Chief Medical Officer of Volition Veterinary Diagnostics said: "The proof of concept results in these two very prevalent canine cancers give us confidence to move forward with other Nu.Q Vet assays in our pipeline, and with the larger range of cohorts and trials we have collected and planned.
"Clearly, we still have work to do as this single assay did not detect one of the other top five canine cancers, canine osteosarcoma, which was the third cancer tested in this study. However, I am delighted to see such positive results in these two significant cancers and look forward to reporting further data over the coming quarters with additional Nu.Q Vet assays, this time tested on an automated platform.”
Dr. Terry Kelly, Chief Scientific Officer of Volition America said: “It is exciting to see such strong results from our first Nu.Q Vet study conducted at Texas A&M University Veterinary Hospital. It is also interesting to note the similar patterns of detection seen in both canine and human samples confirming that the Nu.Q platform does appear to be useful in more than just human diagnostics.
"As with human diagnostics, there are currently no accurate, simple, affordable cancer screening tests available in veterinary medicine and yet 25% of dogs will develop cancer at some stage of their life. I look forward to completing the planned trials and to launch our first Nu.Q Vet product in the U.S. that we expect to occur in 2020."
On top of that, over 25% of vets said they don't talk to their farmer clients about the disposal of empty pharmaceutical waste.
The survey also found that while veterinary surgeons are aware that both glass and shatterproof plastic vials are incinerated, over 65% of those questioned believed that glass vials were more environmentally friendly, when in fact, the company says its CLAS (Ceva Layered Anti Shatter) shatterproof plastic vials have 33% less impact on the environment from cradle to grave2.
Ceva is producing a range of support materials, including tailored social media and newsletter content, to help vets to raise awareness of their pharmaceutical waste disposal service and drive improvements across the industry.
Peter Keyte, ruminant business unit manager at Ceva Animal Health said: "As an industry we should be doing all that we can to improve our environmentally friendly credentials.
“Ceva will continue to invest in innovative eco-friendly technology for livestock injectables and pioneer improvements to help ensure best practice throughout the industry.”
For further information, or to request a pharmaceutical waste disposal service support pack, contact your local Ceva account manager or call 01494 781510.
References
The report is the culmination of the work of a joint RCVS and VSC BAME Student Support Working Group, set up to explore key issues in supporting BAME veterinary students during their studies.
The Working Group made a total of 14 recommendations, which included:
Stephanie-Rae Flicker is a recent Royal Veterinary College (RVC) graduate who co-chaired the Working Group alongside Professor Rob Pettitt from the University of Liverpool.
She said: “I hope this encourages and supports our veterinary institutions to actively implement change regarding discrimination faced during studies and placements, nurturing role models and helping affected students develop sense of belonging and community during their studies and beyond.
"Many thanks to all that have contributed to the completion of this Report – we hope the recommendations have a lasting impact, and benefit those both already present and yet to enter our profession."
RCVS/VSC BAME Student Support Working Group Report.
MSD Animal Health UK has announced the launch of Bravecto, which it says is the first and only treatment available for fleas and ticks in dogs that is rapidly effective and offers 12-weeks duration of efficacy.
Bravecto (fluralaner) is the first of a new generation of systemically active ectoparasiticides, the isoxazolines, and will only be available on prescription through veterinary practices. The new product will be available in five strengths of pork liver flavoured palatable chew for different size dogs - one chew per weight band - which MSD says are readily accepted from the hand. Jolian Howell, marketing and technical lead at MSD Animal Health UK said: "Bravecto is a truly unique and exciting innovation which will transform the effective treatment of fleas and ticks - providing protection like never before from a single dose. It is the first in a new generation of products that offer a full 12-week protection and will help keep the treatment of fleas and ticks within veterinary practices."
He continued: "Estimates suggest that flea and tick treatments are applied for just 2.8 months per year so just one dose of Bravecto will immediately deliver much improved levels of treatment for dogs in veterinary care, which is good for the animal and good for the vet." MSD Animal Health says it is investing in the launch of Bravecto with a major marketing and practice support package which aims to raise awareness of fleas and ticks and drive pet owner footfall into practices for flea and tick control.
The new product will be available after BSAVA Congress, where MSD will be giving visitors the opportunity to learn more about it.
Idexx Laboratories has announced the addition of pradofloxacin (Veraflox, Bayer Animal Health) to the list of antibiotics that it tests samples sent for culture and sensitivity testing against.
The company says that in the past, only a small percentage of the 350-400 samples it processes every day included a specific request from veterinary surgeons to include sensitivity testing to pradofloxacin. The now-routine testing for pradofloxacin is a positive move toward better clinical outcomes in difficult cases, including specific indications such as wound infections, superficial and deep pyoderma, and in cases with infections resistant to other antibiotics.
Idexx says that as the only next generation fluoroquinolone, pradofloxacin has been shown to be the least likely veterinary fluoroquinolone to select for resistance1, giving vets a lower risk option, when they decide to use an antibiotic from this class.
Matt Jones, Microbiology Manager at Idexx Laboratories said: 'Removing the need to specifically request samples to be tested for sensitivity to pradofloxacin has streamlined the culture and sensitivity testing process for vets and will make it easier for them to adhere to good practice in antibiotic prescription.
"This is important, as antimicrobial resistance is an area of deep international concern. Idexx are pleased to be helping vets identify those cases for which pradofloxacin may be effective and believe that, where indicated, it will lead to improved compliance and excellent clinical outcomes with the added benefit of reducing the likelihood of selecting for resistance, when compared to older generation fluoroquinolones."
The company says this move is in line with BSAVA's PROTECT initiative, which stresses the importance of culture and sensitivity, especially when prescribing antibiotics of the fluoroquinlone class.
ATOP 7 Mousse and PYOclean Mousse are presented as a ‘dry shampoo’ in foam form for cats and dogs. They join the company's Dermoscent portfolio of companion animal products, developed to help with the management of scaling disorders, atopic or allergic skin disease and infections.
Both products contain a blend of plant extracts and essential oils from Hemp seed, which LDCA says has a moisturising and restructuring action on the skin. Atop 7 contains lemon tea tree extract, which the company says boosts anti-inflammatory and anti-pruritic activity. PYOclean contains lavender and manuka, which are claimed to have an anti-bacterial action.
LDCA says it has designed the two non-rinse mousses with owner compliance in mind; that used twice-weekly twice-weekly alone or in combination with other supplements or treatments as part of a skincare protocol, they can extend the time between shampoos. They can also be applied quickly to speed patients’ discharge from hospital or used when animals are boisterous or dislike baths.
According to the company, a 2-week veterinary-supervised study looking at the effect of ATOP 7 Mousse on the skin of flea-allergic and atopic dogs, reported a veterinarian general satisfaction score of 8.7/10. Owners of the dogs on the trial reported an 8.7/10 general satisfaction score and a similar score for the product’s ability to soothe irritated skin.¹
The full Dermoscent range, including the new mousses, is available through Vet Direct as well as Henry Schein (selected products) or as a special order through Centaur. ATOP 7 Mousse and PYOclean Mousse are both available in 150ml packs and are priced at £7.94 + VAT each (list price).
For more information visit: http://www.dermoscent.com. A clinical case study by Dr Jean-Loup Mathet on the use of PYOclean Shampoo, Spray and Mousse in a 14-year old West Highland White Terrier with chronic, recurrent, inflammatory, pruritic and seborrhoeic dermatosis is also available online or by request.
Judges for the UK Rabbit Vet of the Year, the Rabbit Nurse of the Year and the Rabbit Veterinary Practice of the Year awards will be looking for exceptional knowledge of rabbit care and husbandry, and evidence of the winners’ continued commitment to educating the public on how to care for rabbits correctly.
Dr Suzanne Moyes MVB MRCVS, awards judge and Veterinary Director at Burgess Pet Care said: "These awards are our way of saying ‘Thank You’ to the veterinary professionals that are helping to improve the lives of pet rabbits."
Rae Todd, Director of the Rabbit Welfare Association & Fund said: "Rabbits make absolutely fantastic pets but research continues to show that there are still too many rabbit owners failing to meet the correct needs of their rabbits. We’re incredibly grateful for the growing number of vets that are working hard to address this, whether that’s by utilising the available rabbit CPD, taking part in events like Rabbit Awareness Week or generally making their practices more suitable environments for rabbit-owning clients."
Veterinary surgeons and nurses can self-nominate for these awards, and nominations are also being sought from the public.
The winners will each receive a cash prize of £500.
To enter the awards, visit www.burgesspetcare.com/excel-vet-awards.